Twenty-five day old female rats were treated with pregnant mare's serum gonadotrophin (PMSG) and human chorionic gonadotrophin (HCG) to achieve a state of luteinization. Eight days after the HCG administration luteolysis was induced by a subcutaneous injection of 5 \g=m\g of the prostaglandin F2\g=a\analogue cloprostenol (Estrumate\s=r\, ICI 80996). In animals treated with 2-Br-\g=a\-ergocryptine(BEC), administration of cloprostenol decreased serum progesterone levels from 580 to 20 ng/ml in 5 h and progesterone remained low for the next 18 h. The serum levels of 20\g=a\-dihydroprogesterone(20\g=a\-DHP) and prolactin (PRL) remained at pre-treatment values (20\g=a\-DHP 85 to 170 ng/ml; PRL less than 5 ng/ml) throughout the observation period. When animals treated with both BEC and cloprostenol were given PRL 5 h after the prostaglandin injection, an increased 20\g=a\-DHPlevel (630 ng/ml) was found 23 h after the cloprostenol administration, while the progesterone level was decreased (70 ng/ml). These findings were similar to the observations following cloprostenol treatment alone. The study indicates a causal relationship between the increase in the serum levels of PRL and 20\g=a\-DHPobserved after PGF2\g=a\ induced luteolysis in rats with superluteinized ovaries. Prostaglandin F2a (PGF2a) administration induces luteolysis in a number of animal species and appears to be the physiological luteolytic factor of uterine origin in most mammals including the rat (for a review see Horton 8c Poyser 1976). The PGF2a induced luteolysis of the superluteinized rat (Parlow 1961) 625 Acta endocr. 87, 3 40 The Hormone and Isotope Laboratory, Aker Hospital, Oslo 5